MLSS Up As Much as 10% in Early Trading

Posted on November 23, 2020 by Aaron Warwick

Milestone Scientific (MLSS), a company engaged in computer-controlled injection technologies and solutions for the medical and dental markets, has been up as much as 10%+ in early trading this morning. MLSS reported earnings last week. Despite being hit hard early in the year due to Covid-19, MLSS guided (conservatively, according to them) for its dental business to be back to normal by Q42020.

In addition to the strong Q4 guidance, MLSS noted a new deal for its dental business in Russia. Furthermore, they noted that some large hospitals have recently expanded their trials of MLSS’s new CompuFlo and CathCheck products, leading the company to believe they will be able to announce formal, long-term deals in the near future. Aaron Warwick has an interview scheduled with MLSS interim-CEO Len Osser tomorrow morning to learn more details. In the meantime, you can read his initial MLSS article on Seeking Alpha: Milestone’s CompuFlo Will Deliver (NYSEMKT:MLSS) | Seeking Alpha

0 0 votes
Article Rating
Notify of
Inline Feedbacks
View all comments
Would love your thoughts, please comment.x